Restoring and maintaining sinus rhythm through cardioversion or catheter ablation improved moderate or worse mitral regurgitation to mild in 77% of patients at 12 months compared to 38% improvement with recurrent atrial fibrillation.
Observational
No
Does rhythm control via cardioversion or ablation improve functional mitral and tricuspid regurgitation in patients with atrial fibrillation?
80 patients with persistent atrial fibrillation (AF) or atrial flutter (AFL) and newly diagnosed at least moderate functional mitral regurgitation (MR), tricuspid regurgitation (TR), or both. Median age 73.7 years, 54% female, single-center (Germany). Excluded: papillary muscle rupture, valve prolapse, leaflet perforation, previous valve surgery, or percutaneous MR and TR intervention.
Rhythm control via electrical cardioversion or catheter ablation (pulmonary vein isolation) to restore sinus rhythm.
Any improvement in valvular regurgitation grade (≥ 1 grade reduction) from baseline to follow-up at 12 months.surrogate
Restoring and maintaining sinus rhythm in patients with atrial fibrillation significantly reduces the severity of functional mitral and tricuspid regurgitation and promotes favorable cardiac reverse remodeling.
Abstract Background Functional mitral and tricuspid regurgitation (MR and TR) are caused by changes in atrial and/or ventricular geometry. Atrial fibrillation (AF) has been identified as a cause of functional MR and TR, but the arrhythmia may also occur as a consequence of the valvular dysfunction. Data on the success of restoring sinus rhythm (SR) and subsequent MR/TR improvement remain limited. This study reports findings from the prospective Berlin-FMTR registry, which included patients with AF and newly diagnosed moderate or worse functional MR or TR undergoing cardioversion or ablation. Methods and results Eighty patients (46% male, median age 73.7 years) with persistent AF and at least moderate MR or TR underwent rhythm control via cardioversion or catheter ablation. Follow-up assessments were conducted at 3 and 12 months. After a mean of 11.6 ± 9 months, 45 patients (56%) remained in SR. At 12 months, 56% of patients with baseline moderate or worse MR improved to mild MR. Among those in SR, this rose to 77% versus 38% with AF recurrence. Only patients in SR showed significant improvements in LVEF, left atrial size, and heart failure symptoms. Similarly, 54% of patients with at least moderate TR at baseline improved to mild TR at 12 months. Among those maintaining SR, 70% showed TR improvement, compared to 35% with recurrent AF. Right ventricular function (TAPSE, RV diameter/volume) improved only in those in SR. Conclusion Restoring and maintaining SR led to significant reductions in MR and TR severity and cardiac remodeling. These findings support rhythm control as a key therapeutic strategy in patients with AF and functional MR/TR. Graphical Abstract
Building similarity graph...
Analyzing shared references across papers
Loading...
Philipp Attanasio
Felix Schwarz
Fabian Barbieri
Clinical Research in Cardiology
Charité - Universitätsmedizin Berlin
German Centre for Cardiovascular Research
Deutsches Herzzentrum der Charité
Building similarity graph...
Analyzing shared references across papers
Loading...
Attanasio et al. (Thu,) conducted a observational in Patients with persistent atrial fibrillation and newly diagnosed at least moderate functional mitral or tricuspid regurgitation undergoing cardioversion or catheter ablation (n=80). Rhythm control via cardioversion or catheter ablation vs. Recurrent atrial fibrillation was evaluated on Improvement in valvular regurgitation grade (≥1 grade reduction) from baseline to 12-month follow-up. Restoring and maintaining sinus rhythm through cardioversion or catheter ablation improved moderate or worse mitral regurgitation to mild in 77% of patients at 12 months compared to 38% improvement with recurrent atrial fibrillation.
www.synapsesocial.com/papers/69994c27873532290d02068a — DOI: https://doi.org/10.1007/s00392-026-02877-8